Resources

Eliminating HPV-related Cervical Cancer: the Role of Preventive Vaccine R&D

Impact Global Health

Summarizes global HPV vaccine R&D funding, key funders, and progress toward cervical cancer elimination to inform investment and policy decisions.

Elinzanetant, A New Combined Neurokinin-1/-3 Receptor Antagonist For The Treatment Of Postmenopausal Vasomotor Symptoms

Hager et al.

Summarizes clinical data, safety, and efficacy of Elinzanetant, a neurokinin-1/-3 antagonist, for non-hormonal treatment of postmenopausal vasomotor symptoms and sleep disturbances.

Emerging Infections and Pregnancy

Jamieson, D. J. et al.

Summarizes how pregnancy alters immune response, increasing susceptibility and severity of emerging infectious diseases, to inform clinical and public health planning.

Emerging Infectious Determinants of Chronic Diseases

O’Connor, S. M. et al.

Summarizes evidence linking infectious agents to chronic diseases, outlines mechanisms involved, and highlights implications for prevention and public health research.

Endometriosis is Undervalued: A Call To Action

Ellis, K. et al.

Summarizes the burden, funding gaps, and current and emerging diagnostic and treatment options for endometriosis to advocate for increased research investment.

Endometriosis: Cost Estimates and Methodological Perspective

Simoens, S. et al.

Reviews data on cost estimates and methodologies for quantifying the economic impact of endometriosis, highlighting gaps and needs for improved research.

Endowed Chairs And Professorships: A New Frontier In Gender Equity

Thorndyke, L. E. et al.

Provides data on gender distribution of endowed positions at U.S. medical schools and reviews strategies to promote women’s representation and equity in academic medicine.

Equity 2030 Alliance: Collective Impact Report 2024 and Beyond

Equity 2030 Alliance

Summarizes collective actions, investments, data, and outcomes advancing gender equity in science, technology, and finance to inform and inspire global change.

Erlotinib Versus Chemotherapy as First-Line Treatment for Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer (Optimal, Ctong-0802): A Multicentre, Open-Label, Randomised, Phase 3 Study

Zhou, C. et al.

Reviews data on the efficacy and safety of pazopanib in advanced renal-cell carcinoma, supporting its use as a first-line treatment option.

European VC Female Founders Dashboard

PitchBook

Provides information on European venture capital investment trends for female-founded startups since 2008, using interactive data sourced from the PitchBook platform.

Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule

Byrne, J. J. et al.

Reviews compliance of new drug labels with the 2015 Pregnancy and Lactation Labeling Rule and summarizes available pregnancy and lactation data sources for regulatory evaluation.

Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex

Porreca et al.

Summarizes sex-specific outcomes of CGRP-targeting therapies for acute and preventive migraine treatment, highlighting differences in efficacy between men and women.

Exploring the Experience of Pain and Pain Management for Pregnant and Postpartum Veterans with Chronic Musculoskeletal Pain

Kroll-Desrosiers

Summarizes experiences, barriers, and recommendations for pain management among pregnant and postpartum veterans with chronic musculoskeletal pain to inform improved VHA care.

Federal Legislative Agenda 2023-2024

Society for Women's Health Research

Summarizes SWHR’s 2023-2024 federal legislative priorities and policy recommendations to advance women’s health research, equity, and access.

FemTech Landscape 2023

 FemHealth Insights

Provides information on FemTech industry trends, startup data, investments, exits, organizations, and predictions to inform stakeholders about the evolving women's health technology landscape.

Fifth Anniversary Of The Sex And Gender Equity In Research (SAGER) Guidelines: Taking Stock And Looking Ahead

Peters, S. A. E. et al.

Summarizes the SAGER guidelines’ role, barriers to implementation, and recommendations for improving sex and gender equity in health research reporting.

Financing for equity for women’s, children’s and adolescents’ health in low- and middle-income countries: A scoping review

Bou-Karroum et al.

Summarizes financing interventions and evidence to improve equity in women's, children's, and adolescents' health in low- and middle-income countries.

Flying Blind: unveiling the patchy landscape of global R&D for endometriosis, polycystic ovary syndrome and uterine fibroids

Impact Global Health

Summarizes global R&D funding, product pipelines, and innovation gaps for endometriosis, PCOS, and uterine fibroids to inform investment and accelerate women’s health progress.